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Psychoti c disorders
Psychoti c disorders aff ect people in multi ple ways and pati ents oft en have to cope with a 
wide range of symptoms.1 Commonly experienced positi ve symptoms are hallucinati ons, 
defi ned as sensory percepti ons in the absence of an external sti mulus (i.e. hearing voices), 
and delusions, which are false or erroneous beliefs that usually involve a misinterpretati on 
of percepti ons or experiences. Some pati ents also exhibit conceptual disorganisati on: they 
have problems in forming coherent thoughts accompanied by incoherent speech that is 
oft en diffi  cult to understand. They may have to cope with other impairments in cogniti ve 
functi oning as well, such as impaired memory and executi ve functi oning, att enti on defi cits, 
decreased processing speed and impairments in social and visual learning and in social cog-
niti on.2,3 Symptoms can also be aff ect-related: pati ents with manic symptoms can exhibit 
agitated behaviour, distracti bility and racing thoughts. Pati ents can experience depressi-
ve symptoms as well.1 More than half of the people with psychoti c disorders suff er from 
so-called negati ve symptoms of psychosis, such as apatheti c social withdrawal, blunted af-
fect, anhedonia and avoliti on.4,5 Blunted aff ect is the reduced intensity of emoti onal expres-
sion, anhedonia is the inability to experience pleasure during normally pleasant acti viti es 
and avoliti on is a general lack of moti vati on to pursue meaningful goals. These negati ve 
symptoms can have a great impact on pati ents’ quality of life. Apathy can make it very 
diffi  cult for pati ents to maintain a job or to functi on in an educati ve setti  ng.6 Also, negati ve 
symptoms may limit a pati ent’s ability to give a desired response to social cues from friends 
and family members, putti  ng pressure on their interpersonal relati onships. The lack or loss 
of social contacts can cause great suff ering and can lead to loneliness and social isolati on.6 
Beside the symptoms of the mental 
illness, people with psychoti c disor-
ders also experience more physical 
health problems than the general 
populati on.7,8 More specifi cally, they 
have an increased risk of developing 
obesity and metabolic risk factors, 
such as hypertension, dyslipidaemia 
and diabetes mellitus type 2 at an 
early age. The metabolic syndrome, 
a constellati on of these interrela-
ted risk factors, puts pati ents at risk 
Box 1: The metabolic syndrome
The metabolic syndrom is defi ned by the Nati o-
nal Cholesterol Educati on Program - Adult Treat-
ment Panel III (NCEP-ATP-III) as the presence of 
three out of fi ve of the following risk factors:
1. Waist circumference ≥ 88 / 102 cm         (f/m)
2. Blood pressure ≥ 130/85 mmHg
3. HDL cholesterol <1.3 / 1.3 mmol/l   (f/m)
4. Triglycerides  ≥ 1.7 mmol/l
5. Fasti ng glucose ≥ 6.1 mmol/l
The criterion for a risk factor is also fulfi lled 
when medicati on for said risk factor is prescri-
bed.
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for  cardiovascuar diseases (BOX 1)*. The increased metabolic risk can reduce their life ex-
pectancy with thirteen to thirty years.9-11 People with psychotic disorders have a two- to 
threefold risk of dying from cardiovascular diseases, with cardiovascular mortality rates 
ranging between 40-50%.12
The Lalonde Model
Traditionally, health care and medicine were considered the source of all health improve-
ments, where the level of health equalled the quality of medical care. However, in 1981 
Marc Lalonde, the Canadian minister of National Health and Welfare of that time, proposed 
a health field concept in which he suggested that health and well-being were dependent 
on determinants outside of the health care systems as well. Specifically, Lalonde identified 
four broad factors that determine health: human biology, environment, lifestyle and health 
care organisation (BOX 2).13 This report inspired several changes in policy and contributed 
to overall health improvements in the population, such as a drop in smoking rates, healthier 
diets and increasing levels of physical activity.14
Human biology
The human biology factor is a combination of the organic make-up of an individual and the 
basic general biology of the human species. Among others, it includes a persons’ genetic 
inheritance and the process of maturation and aging.13 With regard to genetic inheritan-
ce, 108 different loci, specific positions of DNA sequences on chromosomes, have been 
implicated in schizophrenia. Most of these were protein-coding genes.15 Interestingly, the 
Neuregulin 1 (NRG1) gene can make people more susceptible for psychosis, but can also 
increase the risk of developing diabetes mellitus type 2.16,17 Several gene pathways associ-
ated with psychotic disorders were also associated with diabetes mellitus type 2, such as 
calcium, g-secretase mediated ErbB4, adipocytokine, insulin and AKT1 signalling.18 People 
with certain variations of the AKT1 gene have an increased risk of developing a psychotic 
disorder when they are using cannabis.19 At the same time, variations of the AKT1 gene have 
been also associated with an increased Body Mass Index (BMI, kg/m2), increased insulin 
resistance and fasting glucose concentrations, and a higher risk of developing the metabolic 
syndrome.20 Moreover, increased C-Reactive Protein levels (CRP) were associated with both 
psychosis and metabolic risk factors in people with psychotic disorders.21 In addition, a fa-
mily history of non-affective psychosis has been associated with a family history of diabetes 
as well.22
 
* The NCEP-ATP-III has updated the metabolic syndrome criteria in 2005, changing fasting glucose to ≥ 5.6 mmol/l.117 
However, the motives and justification of lowering this threshold were questioned by the European Diabetes Epide-
miology Group (EDEG).134 The EDEG and the World Health Organisation (WHO) therefore recommend to continue 
using fasting glucose to ≥ 6.1 mmol/l.134,135 
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BOX 2: The Lalonde Model of Health; adapted for people with psychoti c disorders
With regard to the process of maturati on and aging, the vascular system of people with 
psychoti c disorders appears to age more rapidly compared to the general populati on. In 
a study that compared obese people with a psychoti c disorder to matched obese controls 
without mental illness, the pati ents’ vascular age was on average 14.1 years higher compa-
red to their actual age, whereas the vascular age of obese controls was 6.7 years higher.11 
The same study showed that the pati ents’ general esti mated cardiovascular risk was 23% 
higher compared to their matched controls. Furthermore, metabolic risk factors appear to 
develop ten to fi ft een years earlier in people with psychoti c disorders compared to the ge-
neral healthy populati on.23
Environment
The environmental factor includes both the physical and social environment. These are the 
health-related issues that are external to the human body, over which the individual can 
exert litt le to no control.13 An important aspect of the environmental factor is the fact that 
people with psychoti c disorders oft en have a low socioeconomic status, which has been 
associated with high unemployment rates and fi nancial diffi  culti es, less physical acti vity and 
unhealthy eati ng behaviour.24 Most of the long-term and residenti al care faciliti es can be 
characterised as ‘obesogenic’, due to abundant provision of unhealthy food products and
    1
 General Introducti on
Layout Proefschrift.indd   13 13-9-2016   22:07:24
14
a lack of daily activities, in which it can be difficult to make healthy choices.25 In recent 
years, nurses increasingly recognise these health risks and try to stimulate healthy lifestyle 
behaviour in patients.26 Impeding access to the market and cheaper supermarkets however, 
sometimes limits patients’ abilities to opt for healthy alternatives. Some psychiatric insti-
tutions have gyms and offer psychomotor therapy, but other institutions have little or no 
adequate exercise facilities. Inpatients may not always be able or allowed to visit external 
sporting facilities. 
For patients who live independently or in protected housing, going to a sporting facility may 
not be an option either, because many patients cannot afford an expensive gym member-
ship.24 Travel distance to external facilities may be a threshold for participating in physical 
activity as well, especially when patients’ personal means of transportation are limited.27-29 
Also, living in a city can limit patients’ physical activity, because they have easy access to 
any daily service they may need, whereas patients living in rural areas may have to walk 
or bike much further to get their basic needs.30 Many patients are unemployed and have a 
lack of occupation during the day.31,32 Sometimes daytime activities are offered, but again, 
not all patients can afford the financial contributions for these activities that are often re-
quired. This lack of daily occupation not only limits physical activity opportunities, but also 
contributes to high prevalence of substance use among people with psychotic disorders in 
comparison to the general population.33,34 
Season and location of birth is an environmental factor that overlaps with human biology, as 
people born in the winter or spring, at a greater distance from the equator, are more likely 
to develop a psychotic disorder.35,36 Likely vitamin D levels play an important role, because 
these are highly dependent on sun exposure and the zenith angle of the sun, which is lowest 
during the winter and spring, especially in countries far north of the equator.37 Therefore, 
prenatal and neonatal vitamin D levels would be lowest during these seasons and affect the 
developing foetal brain the most.38 Moreover, in adult people with psychotic disorders vita-
min D insufficiency is a common finding.39,40 It was found to be associated with more severe 
psychotic symptoms, negative symptoms in particular.41 Studies in the general population 
have also suggested an association between vitamin D deficiency and increased metabolic 
risk, although the direction of this association remains unclear.42-47 
Another environmental factor over which patients have little control but with high impact 
are the stigmatising attitudes within the patient’s environment. People with psychotic disor-
ders are considered by some to be aggressive, dangerous and unreliable, a stereotype that 
is further boosted by the over-simplified manner in which they are often portrayed in the 
media.48,49 Consequently, they have difficulties in finding and keeping a job, finding a place 
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to live and staying in contact with friends and family, which altogether leads to social isolati -
on.48,50-52 This in turn could lead to self-sti gma, where pati ents internalise these negati ve be-
liefs and atti  tudes and eventually expect to be rejected and devaluated by others, because 
they suff er from a psychoti c disorder.53,54 Feeling sti gmati sed, vulnerable and isolated with a 
low self-esteem may be additi onal thresholds for pati ents to join a gym or to att end sporti ng 
events, because they wish to avoid social situati ons.28,55 When they do engage in these so-
cial situati ons, pati ents oft en misinterpret social interacti ons and lack social support, which 
leads to demoralisati on and further decreases their internal moti vati on to parti cipate in 
physical acti vity.28,55
Lifestyle
The lifestyle factor concerns the decisions and behaviours of individuals that aff ect their 
health.13 Compared to the general populati on, people with psychoti c disorders are more 
likely to have diets that are high in saturated fat†, high in calories and sugar and low in 
fi bres,56,57 and are less likely to eat 400 grams of fruit and vegetables on a daily basis, as 
recommended by the World Health Organisati on (WHO).58-61 Pati ents also have a high in-
take of fast food and instant meals, oft en add salt to their food and have a low intake of 
fi sh.59,60,62 Overall, these unhealthy dietary habits can cause weight gain, aggravate metabolic 
risk factors, such as hypertension, dyslipidaemia and diabetes mellitus type 2, and increase 
pati ents’ overall metabolic risk.63-65 Certain nutriti onal habits such as not eati ng enough fatt y 
fi sh and forti fi ed products, for instance margarine and milk, also obstruct the producti on 
of vitamin D in the body.66 Lack of knowledge with regard to food content contributes to 
unhealthy decision making.67 
Physical acti vity rates are generally lower in people with psychoti c disorders compared to 
the general populati on as well.68 Physical inacti vity has been associated with a higher pre-
valence of the metabolic syndrome, thus contributi ng to the increased metabolic risk in 
people with psychoti c disorders.69,70 
There is also a much higher prevalence of smoking, alcohol consumpti on and illicit drug 
use in people with psychoti c disorders compared to the general populati on.56,71,72 Smoking 
is known to lead to increased blood pressure and increased blood pressure variability,73,74 
as well as an increased risk of developing diabetes mellitus type 2.75,76 Heavy use of alcohol 
is associated with a greater risk of obesity, a higher BMI, a greater waist circumference 
and increased hypertension.77-79 Consequently, the high prevalence of smoking and alcohol 
† Saturated fats are mostly found in birds and land animals, whereas unsaturated fats, or polyunsaturated fats, are 
most commonly found in vegetables, fi sh and seafood. Diets high in polyunsaturated fats are considered healthier 
than diets high in saturated fats.338
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use further increases metabolic risk in people with psychotic disorders.80 There is also a 
high prevalence of cannabis use, the most commonly used illicit drug among people with 
psychotic disorders.81-86 The effects of cannabis use on psychotic symptoms have been well 
studied. Several studies have shown that cannabis use can increase the severity of psychotic 
symptoms, but can also trigger a psychosis and lead to a persistence of the symptoms.83-86 
However, very little is known about the effects of cannabis use on metabolic risk factors. 
All of these unhealthy behaviours individually contribute to an increased metabolic risk in 
people with psychotic disorders, but they are also highly interrelated. For example, smoking 
is associated with unhealthy eating habits,59,87,88 unhealthy eating is associated with incre-
ased substance use,62 and smoking, substance use and eating unhealthy food often coincide 
with low physical activity.59,87
Personal decisions are an important factor in the realisation of lifestyle behaviours, but 
unhealthy habits are not always entirely self-imposed. The four factors described by Lal-
onde are not isolated determinants, but also influence each other.13 Symptoms of an ill-
ness and environmental factors can influence unhealthy behaviour, making these habits 
not necessarily a voluntary lifestyle choice. Cognitive impairments and negative symptoms, 
for example, make self-management of a healthy lifestyle very difficult for people with psy-
chotic disorders. Smoking is considered a lifestyle choice, but is highly influenced by perso-
nal environment and socioeconomic status.87 It is also difficult to make a healthy lifestyle 
choice with regard to physical activity, when possibilities to exercise are limited or lacking 
completely. 
Health care organisation
The health care organisation factor refers to the people and resources involved in the pro-
vision of health care. Among others, it includes medical practice, hospitals, medical drugs, 
nursing and health care services.13 Similar to patients’ home environment, stigma is also 
present in the health care setting. Somatic and mental health care workers have stigmati-
sing attitudes towards people with psychotic disorders, which can interfere with the quality 
of care that patients receive.89,90 
During short-term admissions of people with psychotic disorders, health care providers of-
ten have little attention for exercise and healthy nutrition. Although psychiatrists seem to 
be aware of the patients’ increased metabolic risk,91,92 there often appear to be difficulties 
in communication between mental health care workers and primary care physicians with 
regard to who is responsible for monitoring and treating metabolic disorders in these pa-
tients.93,94 Psychiatrists may not consider this type of treatment a part of their job and may 
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feel that primary care physicians are bett er equipped to treat metabolic disorders. On the 
other hand, primary care physicians may feel reluctant to prescribe medicati on to a pati ent 
who is already receiving diff erent types of medicati on in the care of another health care 
professional. Pati ents may also not be referred to a primary care physician for their me-
tabolic disorders, or not follow-up on a referral. About forty years ago in the Netherlands, 
psychiatric care was deinsti tuti onalised on a large scale and gradually moved from being 
hospital-based to a more ambulant care setti  ng,95 which led to a clear disti ncti on between 
somati c care and mental health care. Consequently, the physical health of people with a 
severe mental illness has been ignored for years and the main focus of mental health treat-
ment has been management of psychoti c symptoms, either by Cogniti ve Behavioural Thera-
py or anti psychoti c medicati on. This is especially unfortunate because of the side eff ects of 
anti psychoti c medicati on. The fi rst generati on anti psychoti cs were mostly known for their 
extrapyramidal side eff ects‡, but important and common side eff ects of the recent genera-
ti on anti psychoti cs are weight gain and an increase in metabolic risk factors.96-98
The severity of the metabolic side eff ects of anti psychoti cs varies per drug type.96-98 Olanza-
pine and clozapine present the greatest risk of clinically signifi cant weight gain, increased 
levels of low-density lipoprotein (LDL) cholesterol and triglycerides, decreased high-density 
lipoprotein (HDL) cholesterol and developing diabetes mellitus type 2.97,99-102 Risperidone 
and queti apine are also associated with moderate weight gain and intermediate elevati ons 
of cholesterol and glucose concentrati ons, whereas aripiprazole and ziprasidone have litt le 
to no metabolic side eff ects.99-101 
Several underlying mechanisms have been suggested to explain anti psychoti c induced 
weight gain. It appears that a number of the serotonin-dopamine antagonists alter appeti te 
sensati ons.103 The sati ati ng effi  ciency of food is less strong in people prescribed with these 
anti psychoti cs compared to healthy controls of similar age and physical acti vity levels, and 
pati ents are twice as suscepti ble to feelings of hunger.104 The 5-hydroxytryptamine recep-
tors (5-HT) are known for their importance in signalling sati ety and 5-HT2C antagonists have 
been shown to increase food intake. Especially olanzapine and clozapine were found to 
have high affi  niti es for the 5-HT2C receptor.103 Anti psychoti c drugs also aff ect hypothalamic 
regions in the brain that are involved in controlling food intake. Working as a dopamine-D2 
antagonism, anti psychoti cs infl uence feeding behaviour by blocking the hypothalamic D2 
receptors, which leads to increased food intake.103 With regard to the development of di-
abetes, olanzapine and clozapine work as strong antagonists on the muscarinic M3 recep-
‡ Extrapyramidal side eff ects include but are not limited to dystonia (repeti ti ve movements or abnormal posture 
due to sustained muscle contracti ons), tardive dyskinesia (involuntary and repeti ti ve movements of the body), 
akathisia (feelings of inner restlessness) and parkinsonism (rigidity, tremor and bradykinesia).
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tor.105 They can cause insulin dysregulation by inhibiting the cholinergic stimulation of insu-
lin production and secretion.103,106
Apart from the direct metabolic side effects, antipsychotic drugs indirectly influence me-
tabolic risk as well through their sedative effects.103 Indeed, they are even prescribed to 
promote sleep in people with sleeping disorders in several countries, including the Nether-
lands.28,55,99,107,108 The sedative effects of antipsychotic medication, combined with an obe-
sogenic environment and common negative symptoms such as apathy and loss of initiative, 
render it difficult for patients to engage in physical activities. Therefore, their activities tend 
to be more often of a sedentary§ than a strenuous nature.29,62
In spite of the serious impact of negative symptoms, positive symptoms are often the pri-
mary focus of treatment in psychotic disorders. Cognitive Behavioural Therapy (CBT) is ef-
fective in reducing positive symptoms and preventing relapse, but has little effect on the 
negative symptoms of psychosis.109-112 Similarly, most antipsychotic drugs effectively treat 
the positive symptoms, but many have no or limited effects on the negative symptoms. 
Some antipsychotics, such as clozapine, olanzapine and amisulpride do sometimes slightly 
improve negative symptoms.96 However, they often coincide with more metabolic dysre-
gulation. The extrapyramidal side effects are generally found in antipsychotics with strong 
D2 antagonistic effects.96 The strong D2 antagonism may also lead to flattening of affect, 
anhedonia and loss of initiative, a process referred to as secondary negative symptoms. 
Interestingly, repetitive transcranial magnetic stimulation (rTMS) was found moderately ef-
fective in alleviating negative symptoms.113
When metabolic disorders emerge, the first step guidelines recommend is to switch to an-
tipsychotic medication that is associated with less metabolic dysregulation.114 The second 
step is that patients receive an intervention aimed at adopting a healthier lifestyle. Lifestyle 
interventions can lead to an immediate loss of body weight as well as prevent patients from 
gaining weight.115,116 If changing the prescribed antipsychotic medication and stimulating 
participation in a lifestyle intervention are not effective, or when the metabolic disorders 
are too severe, treatment with antihypertensive, lipid-lowering and antihyperglycemic 
drugs is recommended.117 
The increased metabolic risk in people with psychotic disorders has been ignored for a long 
time. During the last ten years, two large studies investigated treatment rates for metabolic 
§ Sedentary activities require low physical intensity, such as office work, driving, watching TV, eating, reading, 
cooking, going for a walk, shopping and tidying up. Strenuous activities require moderate to rigorous physical inten-
sity, such a jogging, renovating, cleaning, biking, carrying loads, competitive sport and ball games.62
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disorders in US pati ents with psychoti c disorders. Alarming reports from these studies sho-
wed that only 38-54% of the pati ents with hypertension, 11-41% of the pati ents with dys-
lipidaemia and 55-60% of the pati ents with diabetes mellitus received treatment for these 
metabolic disorders.118,119 Since then, the increased metabolic risk of people with psychoti c 
disorders has received growing internati onal att enti on and there is an overall agreement 
that these risk factors need to be monitored.91,120 Routi ne Outcome Monitoring (ROM; 
BOX 3) has been implemented from 2003 onwards in several mental health insti tuti ons in 
the northern Netherlands.8,121-126 Aft er more than ten years of somati c screening, it might be 
expected that pati ents are more frequently treated for their metabolic disorders and that 
overall metabolic risk will have decreased, but no longitudinal studies to date have confi r-
med this so far.
Lalonde convincingly showed that health is not solely the product of medical care, but that 
human biology, environment, lifestyle and the way our we organise our health care system 
infl uence health at least as much. The increased metabolic risk in people with psychoti c 
disorders has received ample att enti on in the past two to three decades, ranging from epi-
demiological reports on shortened life expectancy to geneti c and molecular studies into 
pathways and polymorphisms explaining this increased metabolic risk.127,128 Many issues ho-
wever are sti ll unresolved and although this thesis by no means can complete the puzzle, 
it aims to try and fi ll in some missing pieces of our current knowledge regarding metabolic 
risk factors in people with psychoti c disorders. Data from the Pharmacotherapy Monitoring 
and Outcome Survey (PHAMOUS) allows for the possibility of investi gati ng several of these 
issues. PHAMOUS is an ongoing Dutch cohort study that started in 2006 in four mental 
health insti tuti ons in the northern Netherlands. Pati ents with severe mental illness using an-
ti psychoti c medicati on are invited to parti cipate in annual ROM screenings as part of regular 
clinical practi ce. Data are used for health evaluati on purposes and ROM procedures are fully 
explained to parti cipants, aft er which they are free to opt-out for the use of their anony-
mised data in the research databa-
se. Using these data we aim to fi nd 
out if treatment rates for metabolic 
risk factors in people with psychoti c 
disorders have increased, now that 
ROM has been implemented as part 
of regular clinical practi ce for several 
years. As discussed in this introducti -
on, there are many known factors in 
Lalonde’s health fi eld concept that 
contribute to the increased metabo-
Box 3: Routi ne Outcome Monitoring
Pati ents parti cipate in annual assessments by 
a trained nurse practi ti oner to determine their 
physical and mental health status. Mental health 
measurements include depression, the severity of 
psychoti c disorders, social functi oning and quality 
of life. Physical health measurements include 
waist circumference, body weight, blood pressure 
and a fasti ng blood sample to determine concen-
trati ons of cholesterol, glucose, HbA1c and vitamin 
D among others.
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lic risk of people with psychotic disorders, but there are still factors of which the effect on 
patients’ metabolic risk remain unclear or completely unknown. By investigating vitamin D, 
cannabis use and the mediating role of AKT1 as potentially contributing factors, this thesis 
attempts to fill in some missing pieces of the complicated puzzle that is the metabolic risk 
of people with psychotic disorders. Furthermore, several reviews have demonstrated that 
lifestyle interventions are able to reduce patients’ body weight.115,116 This thesis aims to find 
out if lifestyle interventions are also able to improve patients’ metabolic risk factors, and if 
the effects on body weight are only immediate or long term as well. 
Outline of thesis
In chapter 2 the current treatment rates and course of metabolic disorders over time is 
investigated in a large cohort of people with psychotic disorders, using yearly ROM assess-
ments. The prevalence, incidence and remission rates of the metabolic syndrome is assessed 
over the course of three assessments. Furthermore, the rates of treatment recommendati-
on with antihypertensive, lipid-lowering and antihyperglycemic drugs and rates of patients 
receiving the recommended treatment according to guidelines is investigated. Predictors for 
receiving treatment (e.g. age, illness duration, substance use) and the course of metabolic 
risk factors with and without the recommended treatment are explored. 
Chapter 3 discusses the associations between vitamin D, negative symptom severity and 
metabolic risk, using a continuous Z-score of the metabolic syndrome and its individual com-
ponents. The associations are examined within the four different seasons and separately for 
patients with and without vitamin D supplementation. 
In Chapter 4 it is examined whether cannabis use is associated with metabolic disorders. In 
addition, changes in metabolic disorders from the first to second assessment are investiga-
ted for patients who have continued, discontinued, started or never used cannabis.
Chapter 5 discusses a possible genetic explanation for the association between cannabis use 
and metabolic disorders in people with psychosis. It is examined if certain variations of the 
AKT1 gene, which was found to be associated with the metabolic syndrome, schizophrenia 
and the use of cannabis in previous studies, is a mediating factor in the association between 
cannabis use and BMI and glycated haemoglobin (HbA1c), a measure of average blood gluco-
se levels over an extended period of time.102
Chapter 6 is a meta-analysis that investigates the immediate and long-term effectiveness of 
lifestyle interventions on body weight in people with psychotic disorders. It evaluates both 
the effects on weight loss and the prevention of weight gain. Furthermore, the effects of 
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lifestyle interventi ons on metabolic risk factors and depressive symptoms are investi gated. 
Chapter 7 is a summary of the fi ndings followed by a general discussion and future perspec-
ti ves.     1
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PART I: SEVERITY OF METABOLIC RISK
Layout Proefschrift.indd   23 13-9-2016   22:07:26
24
Layout Proefschrift.indd   24 13-9-2016   22:07:28
